Stock Screener App

無料 -

インストール

Medical Devices

3.83

1.03% -0.04

Elutia Inc (ELUT)

概要ニュース株価時系列 Financials ディスカッション予測

Elutia Inc (ELUT) 最新ニュース

Elutia Inc. (NASDAQ:ELUT) Short Interest Down 62.4% in May - MarketBeat

Elutia (NASDAQ:ELUT) Stock Price Up 1.7% - MarketBeat

Elutia (NASDAQ:ELUT) Trading Up 1.7% - Defense World

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024 - Investing.com India

Investing.com India

Elutia First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript - Seeking Alpha

Elutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor Fitzgerald - MarketBeat

Elutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor Fitzgerald - MarketBeat

SimpliDerm Sales Increase 55%, CanGarooRM on Track for Second Quarter 2024 FDA Clearance - wallstreet:online

wallstreet:online

Elutia (ELUT) to Release Earnings on Thursday - Defense World

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

GlobeNewswire Inc.

Elutia Full Year 2023 Earnings: Misses Expectations - Yahoo Finance

ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q4 2023 - InvestorPlace

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

GlobeNewswire Inc.

Elutia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire Inc.

ELUT Stock Price and Chart — NASDAQ:ELUT - TradingView

2nd tuberculosis outbreak linked to bone grafts in the US - Livescience.com

Livescience.com

Silver Spring regenerative medicine firm Elutia regains Nasdaq compliance as business prospects brighten - The Business Journals

The Business Journals

Elutia submits drug-eluting biomatrix for cardiac implants to FDA - Drug Delivery Business News

Drug Delivery Business News

Acutus torches ablation business to focus on manufacturing - BioWorld Online

BioWorld Online

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update - PR Newswire

Dow Falls 150 Points; AutoZone Earnings Top Views - Markets Insider

Markets Insider

Elutia Stock (NASDAQ:ELUT), Quotes and News Summary - Benzinga

Silver Spring's Aziyo Biologics is now Elutia - The Business Journals

The Business Journals

Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio - GlobeNewswire

$256.01

5.63%

$218.29

1.25%

$107.19

0.21%

$25.69

0.85%

$115.95

1.88%

EW

$87.29

0.43%

Yahooで開く | Google で開く | Finviz で開く